| http://www.w3.org/ns/prov#value | - This press release contains forward-looking statements regarding Sa... http://www.bio-medicine.org/inc/biomed/medicine-technology.asp http://feeds.bio-medicine.org/latest-medical-technologyDate:2/6/2013 V/AIDS. Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia, Huntington's disease and hemoglobinopathies such as beta-thalassemia and sickle cell anemia.
|
